Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial
Michael W. Kattan, Stephanie R. Earnshaw, Cheryl L. McDade, Libby K. Black, Gerald L. Andriole
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial'. Together they form a unique fingerprint.